Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
6.00
+0.08 (1.35%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Tango Therapeutics Revenue

Tango Therapeutics had revenue of $19.88M in the quarter ending June 30, 2024, with 36.15% growth. This brings the company's revenue in the last twelve months to $42.51M, up 26.16% year-over-year. In the year 2023, Tango Therapeutics had annual revenue of $36.53M with 46.93% growth.

Revenue (ttm)
$42.51M
Revenue Growth
+26.16%
P/S Ratio
14.79
Revenue / Employee
$303,636
Employees
140
Market Cap
642.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.53M11.67M46.93%
Dec 31, 202224.86M-12.18M-32.89%
Dec 31, 202137.04M29.39M383.83%
Dec 31, 20207.66M-16.99M-68.94%
Dec 31, 201924.65M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition